BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32597748)

  • 21. MALDI-TOF MS fingerprinting facilitates rapid discrimination of phylotypes I, II and III of Propionibacterium acnes.
    Nagy E; Urbán E; Becker S; Kostrzewa M; Vörös A; Hunyadkürti J; Nagy I
    Anaerobe; 2013 Apr; 20():20-6. PubMed ID: 23485355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Bruker Biotyper Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry System for Identification of Clinical and Environmental Isolates of Burkholderia pseudomallei.
    Wang H; Chen YL; Teng SH; Xu ZP; Xu YC; Hsueh PR
    Front Microbiol; 2016; 7():415. PubMed ID: 27092108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients.
    Desai AP; Stanley T; Atuan M; McKey J; Lipuma JJ; Rogers B; Jerris R
    J Clin Pathol; 2012 Sep; 65(9):835-8. PubMed ID: 22639406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of two matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry methods and API 20AN for identification of clinically relevant anaerobic bacteria.
    Jamal WY; Shahin M; Rotimi VO
    J Med Microbiol; 2013 Apr; 62(Pt 4):540-544. PubMed ID: 23242640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory.
    Lévesque S; Dufresne PJ; Soualhine H; Domingo MC; Bekal S; Lefebvre B; Tremblay C
    PLoS One; 2015; 10(12):e0144878. PubMed ID: 26658918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for non-albicans Candida and uncommon yeast isolates.
    Teke L; Barış A; Bayraktar B
    J Microbiol Methods; 2021 Jun; 185():106232. PubMed ID: 33961963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Typing and Species Identification of Clinical Klebsiella Isolates by Fourier Transform Infrared Spectroscopy and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
    Dinkelacker AG; Vogt S; Oberhettinger P; Mauder N; Rau J; Kostrzewa M; Rossen JWA; Autenrieth IB; Peter S; Liese J
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135233
    [No Abstract]   [Full Text] [Related]  

  • 29. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
    Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
    J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for identifying Burkholderia pseudomallei and Burkholderia thailandensis isolates.
    Li J; Hu W; Zhang F; Li M; Rao C; Lu W
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):191-196. PubMed ID: 30426332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid identification of Burkholderia cepacia complex species recovered from cystic fibrosis patients using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Lambiase A; Del Pezzo M; Cerbone D; Raia V; Rossano F; Catania MR
    J Microbiol Methods; 2013 Feb; 92(2):145-9. PubMed ID: 23201483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.
    van Pelt C; Verduin CM; Goessens WH; Vos MC; Tümmler B; Segonds C; Reubsaet F; Verbrugh H; van Belkum A
    J Clin Microbiol; 1999 Jul; 37(7):2158-64. PubMed ID: 10364579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Custom Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometric Database for Identification of Environmental Isolates of the Genus
    Fergusson CH; Coloma JMF; Valentine MC; Haeckl FPJ; Linington RG
    Appl Environ Microbiol; 2020 May; 86(11):. PubMed ID: 32245762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reliability of MALDI-TOF mass spectrometry in the identification of anaerobic bacteria].
    Vega-Castaño S; Ferreira L; González-Ávila M; Sánchez-Juanes F; García-García MI; García-Sánchez JE; González-Buitrago JM; Muñoz-Bellido JL
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):597-601. PubMed ID: 22521278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants.
    Mott T; Soler M; Grigsby S; Medley R; Whitlock GC
    J Clin Microbiol; 2010 Nov; 48(11):4186-92. PubMed ID: 20810766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.
    Mahenthiralingam E; Bischof J; Byrne SK; Radomski C; Davies JE; Av-Gay Y; Vandamme P
    J Clin Microbiol; 2000 Sep; 38(9):3165-73. PubMed ID: 10970351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
    J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients.
    Degand N; Carbonnelle E; Dauphin B; Beretti JL; Le Bourgeois M; Sermet-Gaudelus I; Segonds C; Berche P; Nassif X; Ferroni A
    J Clin Microbiol; 2008 Oct; 46(10):3361-7. PubMed ID: 18685005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix-assisted laser desorption ionisation time-of-flight mass spectrometry for identification of clinically significant bacteria that are difficult to identify in clinical laboratories.
    Lau SK; Tang BS; Teng JL; Chan TM; Curreem SO; Fan RY; Ng RH; Chan JF; Yuen KY; Woo PC
    J Clin Pathol; 2014 Apr; 67(4):361-6. PubMed ID: 24143023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients.
    Marko DC; Saffert RT; Cunningham SA; Hyman J; Walsh J; Arbefeville S; Howard W; Pruessner J; Safwat N; Cockerill FR; Bossler AD; Patel R; Richter SS
    J Clin Microbiol; 2012 Jun; 50(6):2034-9. PubMed ID: 22495566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.